US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist

59.760
+0.010+0.02%

Trading Nov 19 13:15 ET

2.33BMarket Cap-26560P/E (TTM)

Longboard Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Longboard Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
Aug 1, 2024	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

Aug 1, 20242024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Longboard Pharmaceuticals Earnings Reports

Longboard Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 16:19 ET

Longboard Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 1 16:25 ET

Longboard Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 2 16:20 ET

Longboard Pharmaceuticals | 10-K: FY2023 Annual Report

Mar 12 16:19 ET

Analyst Rating

Updated: Nov 19, 2024

Hold

Buy
16.67%
Hold
83.33%
Sell
0.00%

Price Target

No Data

Heat List

Overall